Your browser doesn't support javascript.
loading
Rates of adverse and serious adverse events in children with cystic fibrosis.
Pittman, Jessica E; Khan, Umer; Laguna, Theresa A; Heltshe, Sonya; Goss, Christopher H; Sanders, Don B.
Afiliación
  • Pittman JE; Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States.
  • Khan U; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, United States.
  • Laguna TA; Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Heltshe S; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, United States; Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States.
  • Goss CH; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, United States; Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States; Division of
  • Sanders DB; Division of Pediatric Pulmonary, Allergy and Sleep Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States. Electronic address: dbsand@iu.edu.
J Cyst Fibros ; 20(6): 972-977, 2021 11.
Article en En | MEDLINE | ID: mdl-33745860

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Cyst Fibros Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Cyst Fibros Año: 2021 Tipo del documento: Article